BRTX
BioRestorative Therapies Inc
NASDAQ: BRTX · HEALTHCARE · BIOTECHNOLOGY
$0.23
+11.60% today
Updated 2026-04-30
Market cap
$5.86M
P/E ratio
—
P/S ratio
16.28x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$0 – $2
Volume
10.4M
BioRestorative Therapies Inc (BRTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |